Deciphering Antitubercular Drug Pharmacokinetics

Tuberculosis (TB) remains a significant global health burden, necessitating effective pharmacological interventions. Antitubercular drugs form the cornerstone of TB treatment, yet their pharmacokinetics (PKs) play a critical role in determining efficacy, safety, and treatment outcomes. This abstract provides a comprehensive review of the PKs of key antitubercular drugs, elucidating their absorption, distribution, metabolism, and elimination profiles. Understanding the PK properties of these drugs is crucial for optimizing therapeutic regimens, ensuring adequate drug exposure, and minimizing the risk of adverse effects. Factors influencing drug PKs, such as patient characteristics, drug interactions, and disease severity, are also discussed. Moreover, advancements in PK modeling and simulation techniques offer valuable insights into individualized dosing strategies and therapeutic monitoring. By deciphering the intricate PKs of antitubercular drugs, clinicians and researchers can enhance treatment efficacy and contribute to the global efforts toward combating TB.